Humoral serological response to the BNT162b2 vaccine after allogeneic haematopoietic cell transplantation

OBJECTIVES: To assess the humoral immune response to the BNT162b2 vaccine after allogeneic haematopoietic cell transplantation (HCT). METHODS: This is a prospective cohort study. The SARS-CoV-2 IgGII Quant (Abbott©) assay was performed 4–6 weeks after the second BNT162b2 vaccine for quantitative mea...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeshurun, Moshe, Pasvolsky, Oren, Shargian, Liat, Yahav, Dafna, Ben-Zvi, Haim, Rubinstein, Maly, Sela-Navon, Michal, Wolach, Ofir, Raanani, Pia, Rozovski, Uri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2022
Materias:
Research Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553414/
https://www.ncbi.nlm.nih.gov/pubmed/34715348
http://dx.doi.org/10.1016/j.cmi.2021.10.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553414/
https://www.ncbi.nlm.nih.gov/pubmed/34715348
http://dx.doi.org/10.1016/j.cmi.2021.10.007

Ejemplares similares